Common drug could halt Diabetes-Related blindness
NCT ID NCT03161652
Summary
This study is testing whether levosulpiride, a medication that increases prolactin hormone levels, can improve vision and reduce retinal damage in people with diabetic retinopathy and macular edema. Researchers will compare the drug against a placebo in 120 participants aged 40-69 to see if it safely improves visual acuity and reduces retinal swelling. The goal is to find a new oral treatment option that might work alongside or instead of current eye injections and laser therapies.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC RETINOPATHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Instituto Mexicano de Oftalmologia (IMO)
RECRUITINGQuerétaro City, Querétaro, 76090, Mexico
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Instituto de la Retina del Bajio SC (INDEREB)
RECRUITINGQuerétaro City, Querétaro, 76187, Mexico
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.